Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 3
2003 1
2004 2
2005 2
2006 1
2007 3
2008 2
2009 3
2010 7
2011 5
2012 1
2013 1
2014 4
2015 14
2016 17
2017 12
2018 14
2019 10
2020 8
2021 10
2022 1
2023 5
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

112 results

Results by year

Filters applied: . Clear all
Page 1
Frequency and mutational spectrum of PIK3CA gene mutations in breast cancer patients: Largest and first report from Lebanon.
Hamadeh LN, Farhat L, Hilal L, Assi H, Nasr F, Chahine G, Kattan J, Farhat F, Kourie H, El Hachem G, Ghosn M, El Saghir N, Chamseddine N, Finianos A, Ghanem H, Younes A, Gerges DA, Temraz S, Haidar M, Nabhan T, Chamseddine A, Tfayli A, Zaatari G, Mahfouz R. Hamadeh LN, et al. Among authors: ghosn m. Gene. 2023 Jun 30;871:147433. doi: 10.1016/j.gene.2023.147433. Epub 2023 Apr 15. Gene. 2023. PMID: 37068694
Diagnosis and management of patients with stage III non‑small cell lung cancer: A joint statement by the Lebanese Society of Medical Oncology and the Lebanese Pulmonary Society (Review).
Aoun-Bacha Z, Bitar N, Saleh WA, Assi H, Bahous J, Boukhalil P, Chami H, Dabar G, El Karak F, Farhat F, Ghanem H, Ghosn M, Juvelikian G, Nasr F, Nehme R, Riachy M, Tabet G, Tfayli A, Waked M, Youssef P. Aoun-Bacha Z, et al. Among authors: ghosn m. Oncol Lett. 2023 Feb 6;25(3):113. doi: 10.3892/ol.2023.13699. eCollection 2023 Mar. Oncol Lett. 2023. PMID: 36844621 Free PMC article. Review.
Clinical outcomes after 4.5 years of eliglustat therapy for Gaucher disease type 1: Phase 3 ENGAGE trial final results.
Mistry PK, Lukina E, Ben Turkia H, Shankar SP, Baris Feldman H, Ghosn M, Mehta A, Packman S, Lau H, Petakov M, Assouline S, Balwani M, Danda S, Hadjiev E, Ortega A, Foster MC, Gaemers SJM, Peterschmitt MJ. Mistry PK, et al. Among authors: ghosn m. Am J Hematol. 2021 Sep 1;96(9):1156-1165. doi: 10.1002/ajh.26276. Epub 2021 Jul 11. Am J Hematol. 2021. PMID: 34161616 Free PMC article. Clinical Trial.
112 results